Clinical trial
Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
NCT00171873 is registered in ClinicalTrials.gov with Carmen Schade-Brittinger as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
- Lead sponsor
- Carmen Schade-Brittinger
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2001
- Completion date
- December 31, 2013
- Enrollment
- 85 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.